ES2196785T3 - Derivados de 2-aminoquinalina que tienen actividad agonista del receptor d4. - Google Patents

Derivados de 2-aminoquinalina que tienen actividad agonista del receptor d4.

Info

Publication number
ES2196785T3
ES2196785T3 ES99910210T ES99910210T ES2196785T3 ES 2196785 T3 ES2196785 T3 ES 2196785T3 ES 99910210 T ES99910210 T ES 99910210T ES 99910210 T ES99910210 T ES 99910210T ES 2196785 T3 ES2196785 T3 ES 2196785T3
Authority
ES
Spain
Prior art keywords
group
amino
substituents
different
same
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES99910210T
Other languages
English (en)
Inventor
Hartog Jacobus A J Den
Gerben M Visser
Steen Bartholomeus J Van
Martinus T M Tulp
Eric Ronken
Cornelis G Kruse
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Duphar International Research BV
Original Assignee
Duphar International Research BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Duphar International Research BV filed Critical Duphar International Research BV
Application granted granted Critical
Publication of ES2196785T3 publication Critical patent/ES2196785T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Abstract

Un compuesto de la fórmula (I) o una sal del mismo donde - (R1)n representa 1 ó 2 sustituyentes, que pueden ser iguales o diferentes, del grupo alquilo C1-3 o alcoxi, halógeno, trifluorometilo, nitro, amino y mono- o di-alquil- amino (C1-2), o dos grupos R1 en átomos de carbono adyacentes, junto con el anillo de benceno, pueden formar el grupo benzodioxano o benzofurano, - X representa nitrógeno o carbono y la línea punteada puede representar un doble enlace, - (R2)p representa 0, 1 ó 2 sustituyentes, que pueden ser iguales o diferentes, del grupo metilo y etilo, o (R2)p es un puente de metileno o un puente de etileno, - R3 es hidrógeno o metilo, y - (R)m, representa 0, 1 ó 2 sustituyentes, que pueden ser iguales o diferentes, y pueden estar situados en todas las posiciones disponibles del grupo quinolilo, del grupo alquilo C1-3 o alcoxi, halógeno, trifluorometilo, nitro, amino y mono- o di-alquil-amino (C1-2), - entendiendo que R1 no puede representar o-OCH3 cuando X es nitrógeno, (R2)p y R3 son hidrógeno, m es 0, y n es 1.
ES99910210T 1998-02-09 1999-02-05 Derivados de 2-aminoquinalina que tienen actividad agonista del receptor d4. Expired - Lifetime ES2196785T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98200399 1998-02-09

Publications (1)

Publication Number Publication Date
ES2196785T3 true ES2196785T3 (es) 2003-12-16

Family

ID=8233375

Family Applications (1)

Application Number Title Priority Date Filing Date
ES99910210T Expired - Lifetime ES2196785T3 (es) 1998-02-09 1999-02-05 Derivados de 2-aminoquinalina que tienen actividad agonista del receptor d4.

Country Status (9)

Country Link
US (1) US6281216B1 (es)
EP (1) EP1054863B1 (es)
JP (1) JP4530535B2 (es)
AT (1) ATE239702T1 (es)
AU (1) AU2925799A (es)
CA (1) CA2320116C (es)
DE (1) DE69907636T2 (es)
ES (1) ES2196785T3 (es)
WO (1) WO1999040068A2 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6313141B1 (en) * 1997-06-13 2001-11-06 Neurogen Corporation 2-aminoalkylaminoquinolines as dopamine D4 ligands
DE60012355T2 (de) * 1999-10-22 2005-12-22 Sanofi-Aventis Phenyl- und pyridyl-tetrahydro-pyridine mit tnf inhibitorischer wirkung
EP1177792A3 (en) 2000-07-27 2002-10-23 Pfizer Products Inc. Dopamine D4 Ligands for the treatment of novelty-seeking disorders
FR2933977B1 (fr) 2008-07-18 2013-04-26 Centre Nat Rech Scient Derives heterocycliques utiles dans le traitement des maladies neurodegeneratives
WO2010135571A1 (en) * 2009-05-20 2010-11-25 Cylene Pharmaceuticals, Inc. Novel protein kinase modulators

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5093333A (en) 1991-04-29 1992-03-03 American Home Products Corporation N-substituted-2-aminoquinolines useful for treating hypofunction of the cholinergic system
MX9201991A (es) 1991-05-02 1992-11-01 Jonh Wyeth & Brother Limited Derivados de piperazina y procedimiento para su preparacion.
SK284341B6 (sk) * 1994-09-30 2005-02-04 Pfizer Inc. 2,7-Substituované oktahydro-1H-pyrido[1,2-a]pyrazínové deriváty a farmaceutické prostriedky na ich báze
FR2734819B1 (fr) 1995-05-31 1997-07-04 Adir Nouveaux composes de la piperazine, de la piperidine et de la 1,2,5,6-tetrahydropyridine, leur procede de preparation et les compositions pharmaceutiques les contenant
HUP9900611A3 (en) * 1995-12-21 2000-09-28 Pfizer 2,7-substituted octahydro-pyrrolo[1,2-a]pyrazine derivatives, pharmaceutical compositions containing them and intermediates for the preparation of the compounds
TW593290B (en) * 1996-05-10 2004-06-21 Janssen Pharmaceutica Nv Alkylaminobenzothiazole and -benzoxazole derivatives
CA2293480A1 (en) * 1997-06-13 1998-12-17 Neurogen Corporation 2-aminoalkylaminoquinolines as dopamine d4 ligands

Also Published As

Publication number Publication date
ATE239702T1 (de) 2003-05-15
CA2320116C (en) 2011-02-01
JP2002502843A (ja) 2002-01-29
DE69907636T2 (de) 2004-03-25
EP1054863B1 (en) 2003-05-07
DE69907636D1 (de) 2003-06-12
CA2320116A1 (en) 1999-08-12
EP1054863A2 (en) 2000-11-29
US6281216B1 (en) 2001-08-28
WO1999040068A3 (en) 1999-11-25
WO1999040068A2 (en) 1999-08-12
AU2925799A (en) 1999-08-23
JP4530535B2 (ja) 2010-08-25

Similar Documents

Publication Publication Date Title
TR199801641T2 (xx) Tropan t�revleri bunlar�n haz�rlanmas� ve kullan�m�
DK0765314T3 (da) Benzoheterocykliske derivater, der kan anvendes som vasopressin- eller oxytocinmodulatorer
EA200301073A1 (ru) N-(2-арилэтил)бензиламины в качестве антагонистов 5-ht-рецептора
ATE366724T1 (de) Kondensierte heterocyclische derivate
DK0687251T3 (da) 1,3-dihydroindol-2-on-derivater, der er substitueret i 3-stillingen med en nitrogengruppe, til anvendelse som vasopressin- og/eller ocytocin-agonister og/eller -antagonister
HUP9800295A2 (hu) Szubsztituált heterociklusos vegyületek, eljárás előállításukra és a vegyületeket tartalmazó gyógyszerkészítmények, intermedierjeik
NO20032253D0 (no) Piperazinylpyrazinforbindelser som antagonister av serotonin 5-HT2-reseptorer
EA200101177A1 (ru) Производные индола в качестве антагонистов прогестерона
TR199902883T2 (xx) NK-2 ve NK-3 resept�r antagonistleri olarak kuinolin-4-karboksamid t�revleri.
EA200300619A1 (ru) Серотонинергические средства
AR029400A1 (es) Derivados de isoxazolcarboxamida, un metodo para su preparacion y una composicion farmaceutica que los comprende
EA200200732A1 (ru) Замещенные производные фенилпиперазина, их получение и применение
ES2154470T3 (es) Derivados de tetrahidroisoquinolina y su uso farmaceutico.
ES2196785T3 (es) Derivados de 2-aminoquinalina que tienen actividad agonista del receptor d4.
ES2183866T3 (es) Derivados de beta-aril y beta-heteroaril-alfa-cianoacrilamidas sustituido como inhibidors de la tirosina quinasa.
AU3327399A (en) Benzisoxazole derivatives having d4-antagonistic activity
IT1320162B1 (it) Derivati della tirosina ad attivita' anti leucotrienica, procedimentoper la loro preparazione e loro uso farmaceutico.
WO2004046107A8 (en) Indole derivatives as somatostatin agonists or antagonists
PT1204658E (pt) Agonistas benzofurilpiperazina de serotonina
HUP0203603A2 (hu) Új IL-8 receptor antagonista hatású indolszármazékok és ezeket tartalmazó gyógyszerkészítmények
EA200200727A1 (ru) Новые производные индола
HUP0004565A2 (hu) Szubsztituált krománszármazékok, intermedierjeik és azokat tartalmazó gyógyszerkészítmények
FI20031455A0 (fi) Sulfonyyliamino-peptidomimeettejä, jotka ovat aktiivisia somatostatiinireseptorialatyyppien 4 (SSTR4) ja 1 (SSTR1) suhteen
AU5624599A (en) Pharmaceutical uses
BR9911843A (pt) 4 5 6 7-indol e derivados de indolina, preparação e utilização dos mesmos